Evidence map›Paper›PMID 19796952›Full record

SynthesisJournal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia2009

A systematic review of intracranial chondrosarcoma and survival.

Orin G Bloch, Brian J Jian, Isaac Yang, Seunggu J Han, Derick Aranda, Brian J Ahn, Andrew T Parsa

Registry-linked trialAbstract readSystematic Review
In one paragraph

Synthesis in Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05861245 (Phase II Clinical Trial of Low-intervention Using Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base), which is not on this map. Cited by 61 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 7 pooled it
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05861245 narecruitingnot on this mapstarted 2023, after this paper: background citation

Phase II Clinical Trial of Low-intervention Using Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base

TypeinterventionalSponsorQuironsaludRan2023 to 2033Enrolled20ConditionsChordoma, ChondrosarcomaArms5-fraction hipofractionated protontheray, 25-fraction hypofractionated proton therapy
3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 7 syntheses or guidelines pooled it, 159 citations in OpenAlex.

  1. CT and MRI findings of intracranial extraskeletal mesenchymal and myxoid chondrosarcoma: report of 3 rare cases and literature review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Pooled it
  2. Extra-skeletal intracranial mesenchymal chondrosarcoma: systematic-literature review.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2024
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. [Clinical analysis of endoscopic transnasal resection of skull base chondrosarcoma].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Diagnostics ofDiagnostics (Basel, Switzerland) · 2024
    Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Orin G BlochDepartment of Neurological Surgery, University of California at San Francisco, 505 Parnassus Avenue, San Francisco, California 94143, USA.
Brian J Jian
Isaac Yang
Seunggu J Han
Derick Aranda
Brian J Ahn
Andrew T Parsa
Neurological Surgery · USUniversity of California, San Francisco · US

Funding

Glioma Associated Macrophages Facilitate Local ImmunosuppressionF32CA153839 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BLOCH, ORIN · 2010 to 2010
$54k
B7-H1 mediated expansion of regulatory T-cells in malignant gliomaF32NS071852 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JIAN, BRIAN JOOBEEN · 2010 to 2010
$54k
Howard Hughes Medical InstituteNCI NIH HHS F32 CA153839NINDS NIH HHS F32 NS071852
6 · The paper itself

Abstract

Most data regarding survival in patients with chondrosarcoma are limited to case studies and small series performed at single institutions. A systematic review was performed to study the relationship between potential prognostic factors and survival. The survival rates were analyzed according to modality of treatment, treatment history, histological subtype, and histological grade. A total of 560 patients with intracranial chondrosarcoma were analyzed. Median follow-up time was 60 months. The 5-year mortality among all patients was 11.5% with median survival of 24 months. Mortality at 5 years was significantly greater for patients with tumors of higher grade, or of the mesenchymal subtype, or who had received surgical resection alone. The results of our systematic review provide useful data in predicting survival among intracranial chondrosarcoma patients.

Indexed as

Chi-Square DistributionChondrosarcomaDatabases, FactualHumansLongitudinal StudiesPrognosisSkull Base NeoplasmsSurvival Rate

Identifiers

PMID19796952
PMCPMC3795514
OpenAlexW2047543840

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.